A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Recruiting

Back to Acute Lymphoblastic Leukemia trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

China

Beijing Children's Hospital.Capital Medical University, Beijing, Beijing Municipality

Beijing GoBroad Boren Hospital, Beijing, Beijing Municipality

Pediatric Hematology department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei

Xiehe Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei

The Second Xiangya Hospital, Central South University, Changsha, Hunan

Children's Hospital Of Soochow University, Suzhou, Jiangsu

The First Affiliated Hospital Of Nanchang University, Nanchang, Jiangxi

West China Second University Hospital,Sichuan University, Chengdu, Sichuan

Institute Of Hematology&Blood Diseases Hospital,Chinese Academy Of Medicai Sciences, Tianjin, Tianjin Municipality

Trial locations(10 sites)

Interested in joining?